Israel’s Amorphical (see here previously) announced positive interim results from its ongoing open-label clinical trial evaluating its amorphous calcium carbonate therapy for the treatment of moderate-to-severe Crohn’s disease.
Positive results in Crohn’s treatment trial
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.